Psychedelic clinical trial for Treatment-Resistant Depression

For further information see HMR Leaflet
HMR (TRD)Trials Leaflet

HMR is looking for people with a diagnosis of Treatment-Resistant Depression (TRD) i.e depression that has not responded to two or more
medications, aged 18 to 75 to take part in a trial using 5-MEO-DMT.

5-MEO-DMT is a controlled and ‘psychedelic’ drug, used both recreationally and in ceremonial settings. We are testing whether 5-MEO-DMT given together with psychological support is safe in patients with TRD to determine whether it is useful to investigate further as a treatment for this condition.

If you are someone with TRD and are willing/able to discontinue your antidepressant medication, you might be eligible for this study. You could also be eligible if you are not taking any antidepressants currently, but have tried two or more within this episode.

TO TAKE PART YOU MUST:

Have Treatment Resistant Depression (TRD)

Be aged 18 to 75

TO TAKE PART YOU MUST NOT:

Have taken any psychedelic substances in the last 6 months

Plan to take any psychedelic substances (other than the study drug) during the study

Be addicted to drugs or alcohol

Have an important mental disorder (other than TRD)

THE STUDY INVOLVES:

1 night’s residence on our wards

11 outpatient visits

(4 of them can be video calls)

STUDY PAYMENT:

In return, you’ll receive a full medical

check-up and, if you complete the study,

a payment of £300 + reasonable travel expenses.

Contact Information


Phone Number 0800 783 87 92

E-mail Address recruit@hmrlondon.com


Our Location
Cumberland Avenue,
Park Royal,
London, NW10 7EW